ReWalk has filed for a $58 million initial public offering and will list on the Nasdaq under the symbol RWLK, according to a report in The Wall Street Journal. The news item says the company formerly known as Argo Medical Technologies will use the funds to support development of its robotic exoskeleton for people with spinal cord injury.
Earlier this month, reports swirled about the imminent IPO offering.
It was an article by ISRAEL21c that first introduced the public to this fantastic and innovative device.
ReWalk is the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use.
The Wall Street Journal reports that Barclays Capital and Jefferies are joint book runners on the deal.